Literature DB >> 22965735

Production of interleukin-27 by human neutrophils regulates their function during bacterial infection.

Darawan Rinchai1, Prasong Khaenam, Chidchamai Kewcharoenwong, Surachat Buddhisa, Rungnapa Pankla, Damien Chaussabel, Gregory J Bancroft, Ganjana Lertmemongkolchai.   

Abstract

Septicemia is the most severe form of melioidosis caused by the Gram-negative bacterium, Burkholderia pseudomallei. Here, we show that levels of IL-27p28 transcript and protein were both significantly elevated in patients with sepsis, particularly melioidosis and in patients with unfavorable disease outcome. Moreover, human monocytes/macrophages and neutrophils were the major source of IL-27 during infection. The addition of exogenous IL-27 in vitro resulted in significantly increased bacterial survival, reduced B. pseudomallei-induced oxidative burst, and enhanced IL-1β and TNF-α production by purified neutrophils from healthy subjects. Finally, blockade of endogenous IL-27 in neutrophils using soluble IL-27 receptor antagonist prior to infection led to significantly reduced survival of bacteria and decreased IL-1β, but not TNF-α production. These results indicate a potential role for IL-27 in the suppression of anti-bacterial defense mechanisms that might contribute to disease severity in sepsis. The targeting of this cytokine may be beneficial in the management of human sepsis.
© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22965735      PMCID: PMC3711522          DOI: 10.1002/eji.201242526

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  41 in total

1.  Type I cytokine profiles of human naïve and memory B lymphocytes: a potential for memory cells to impact polarization.

Authors:  Alenka Gagro; Drazen Servis; Alma-Martina Cepika; Kai-Michael Toellner; Gillian Grafton; Dale R Taylor; Srecko Branica; John Gordon
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

Review 2.  Melioidosis: epidemiology, pathophysiology, and management.

Authors:  Allen C Cheng; Bart J Currie
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

3.  Extracellular nucleotide signaling by P2 receptors inhibits IL-12 and enhances IL-23 expression in human dendritic cells: a novel role for the cAMP pathway.

Authors:  Max Schnurr; Tracey Toy; Amanda Shin; Moritz Wagner; Jonathan Cebon; Eugene Maraskovsky
Journal:  Blood       Date:  2004-10-14       Impact factor: 22.113

Review 4.  Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei.

Authors:  W Joost Wiersinga; Tom van der Poll; Nicholas J White; Nicholas P Day; Sharon J Peacock
Journal:  Nat Rev Microbiol       Date:  2006-04       Impact factor: 60.633

5.  A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes.

Authors:  O Devergne; M Hummel; H Koeppen; M M Le Beau; E C Nathanson; E Kieff; M Birkenbach
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

6.  A live experimental vaccine against Burkholderia pseudomallei elicits CD4+ T cell-mediated immunity, priming T cells specific for 2 type III secretion system proteins.

Authors:  Ashraful Haque; Karen Chu; Anna Easton; Mark P Stevens; Edouard E Galyov; Tim Atkins; Rick Titball; Gregory J Bancroft
Journal:  J Infect Dis       Date:  2006-09-25       Impact factor: 5.226

7.  Role of T cells in innate and adaptive immunity against murine Burkholderia pseudomallei infection.

Authors:  Ashraful Haque; Anna Easton; Debbie Smith; Anne O'Garra; Nico Van Rooijen; Ganjana Lertmemongkolchai; Richard W Titball; Gregory J Bancroft
Journal:  J Infect Dis       Date:  2005-12-27       Impact factor: 5.226

8.  Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27.

Authors:  Stefan Wirtz; Ingrid Tubbe; Peter R Galle; Hans J Schild; Mark Birkenbach; Richard S Blumberg; Markus F Neurath
Journal:  J Exp Med       Date:  2006-07-31       Impact factor: 14.307

9.  Regulation of IL-27 p28 gene expression in macrophages through MyD88- and interferon-gamma-mediated pathways.

Authors:  Jianguo Liu; Xiuqin Guan; Xiaojing Ma
Journal:  J Exp Med       Date:  2007-01-16       Impact factor: 14.307

10.  Helper T cell IL-2 production is limited by negative feedback and STAT-dependent cytokine signals.

Authors:  Alejandro V Villarino; Cristina M Tato; Jason S Stumhofer; Zhengju Yao; Yongzhi K Cui; Lothar Hennighausen; John J O'Shea; Christopher A Hunter
Journal:  J Exp Med       Date:  2007-01-16       Impact factor: 14.307

View more
  24 in total

1.  Migration of dendritic cells facilitates systemic dissemination of Burkholderia pseudomallei.

Authors:  Natasha L Williams; Jodie L Morris; Catherine M Rush; Natkunam Ketheesan
Journal:  Infect Immun       Date:  2014-07-28       Impact factor: 3.441

Review 2.  Re-Examining Neutrophil Participation in GN.

Authors:  Dawn J Caster; David W Powell; Irina Miralda; Richard A Ward; Kenneth R McLeish
Journal:  J Am Soc Nephrol       Date:  2017-06-15       Impact factor: 10.121

Review 3.  Neutrophils in innate and adaptive immunity.

Authors:  Sébastien Jaillon; Maria Rosaria Galdiero; Davide Del Prete; Marco Antonio Cassatella; Cecilia Garlanda; Alberto Mantovani
Journal:  Semin Immunopathol       Date:  2013-04-04       Impact factor: 9.623

Review 4.  Defects in innate and adaptive immunity in patients with sepsis and health care associated infection.

Authors:  Thomas Ryan; John D Coakley; Ignacio Martin-Loeches
Journal:  Ann Transl Med       Date:  2017-11

5.  Conditional Macrophage Depletion Increases Inflammation and Does Not Inhibit the Development of Osteoarthritis in Obese Macrophage Fas-Induced Apoptosis-Transgenic Mice.

Authors:  Chia-Lung Wu; Jenna McNeill; Kelsey Goon; Dianne Little; Kelly Kimmerling; Janet Huebner; Virginia Kraus; Farshid Guilak
Journal:  Arthritis Rheumatol       Date:  2017-08-08       Impact factor: 10.995

6.  Burkholderia pseudomallei Capsule Exacerbates Respiratory Melioidosis but Does Not Afford Protection against Antimicrobial Signaling or Bacterial Killing in Human Olfactory Ensheathing Cells.

Authors:  Samantha J Dando; Deepak S Ipe; Michael Batzloff; Matthew J Sullivan; David K Crossman; Michael Crowley; Emily Strong; Stephanie Kyan; Sophie Y Leclercq; Jenny A K Ekberg; James St John; Ifor R Beacham; Glen C Ulett
Journal:  Infect Immun       Date:  2016-06-23       Impact factor: 3.441

7.  The effects of CD14 and IL-27 on induction of endotoxin tolerance in human monocytes and macrophages.

Authors:  Carlene Petes; Victoria Mintsopoulos; Renée L Finnen; Bruce W Banfield; Katrina Gee
Journal:  J Biol Chem       Date:  2018-09-21       Impact factor: 5.157

8.  Interleukin-27 Is a Potential Rescue Therapy for Acute Severe Colitis Through Interleukin-10-Dependent, T-Cell-Independent Attenuation of Colonic Mucosal Innate Immune Responses.

Authors:  Mairi H McLean; Caroline Andrews; Miranda L Hanson; Walter A Baseler; Miriam R Anver; Emilee Senkevitch; Aleksandra K Staniszewska; Christopher Smith; Luke C Davies; Julie Hixon; Wenqeng Li; Wei Shen; Lothar Steidler; Scott K Durum
Journal:  Inflamm Bowel Dis       Date:  2017-11       Impact factor: 5.325

Review 9.  IL-30 (IL-27A): a familiar stranger in immunity, inflammation, and cancer.

Authors:  Booki Min; Dongkyun Kim; Matthias J Feige
Journal:  Exp Mol Med       Date:  2021-05-28       Impact factor: 12.153

Review 10.  Interleukin-27 and Its Diverse Effects on Bacterial Infections.

Authors:  Yugo Morita; Elysia A Masters; Edward M Schwarz; Gowrishankar Muthukrishnan
Journal:  Front Immunol       Date:  2021-05-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.